Publications

Canada stands at a pivotal moment to leverage its natural resource boom into long-term industrial strength by tying faster permitting and land access to reinvestment in innovation. A modest levy on resource extraction could fund a new federal agency focused on turning Canadian R&D into real production and globally competitive advanced industries.

When the history is written about why the world didn’t solve climate change as it should have, much of the blame should be placed on the environmentalists who gave short shrift to the critical need for innovation—and even attacked those who called for it.

ITIF respectfully urges the FRA to approve the requested relief and to initiate broader regulatory modernization that embraces autonomous safety technologies.

The tax provision allowing firms to fully expense their R&D costs in the year of investment expired, decreasing the incentive to invest in this key driver of economic growth and competitiveness. Congress should pass the American Innovation and R&D Competitiveness Act of 2025 to restore the immediate deductibility of R&D expenses.

While the ultimate ruling by Judge Boasberg remains uncertain, the tea leaves do seem to point to yet another defeat for the FTC against Meta.

President Trump has announced his intention to regulate U.S. drug prices. But the arguments in favor of doing so are wrong. Price controls reduce development of new treatments and cures, and hurt U.S. biopharmaceutical competitiveness.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

President Trump’s executive order takes aim at nuclear regulations, but without broader support for innovation, development, and scale-up, America’s nuclear ambitions will remain stuck on the launchpad.

While targeted rules and regulations which address real market failures and improve the status quo can be defensible, there are many that do not benefit competition or consumers and should likely be rescinded.

Canadian firms are underinvesting in productivity-enhancing capital such as machinery, software, and advanced technologies. Without targeted reforms to boost investment and improve data collection, Canada risks falling further behind in global competitiveness and economic growth.